Page 45 - கூட்டணி க்கு பெருவாரியாக பரவும் தொற்று நோய் ப்ரிப்யாரெட்நெஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

A Paris street sweeper poses for a picture, March 4, 2021. Photo: Reuters/Gonzalo Fuentes. The current controversy around intellectual property rights has focused on the role of intellectual property in the current COVID-19 vaccine shortage. But the present situation should not be understood as a manifestation of an exceptional legal event. Rather, it is a reflection of the legal normal that has been in place for the last twenty-five years since the 1995 TRIPS Agreement that forms the legal transnational structure for intellectual property-driven knowledge capitalism. Patent rights grant monopoly power to their holders – mostly multinational corporations. The problems that these transnational monopoly rights cause have been well-known: patents on medical inventions, in particular, have provided  pharmaceutical corporations, as well as the more under the radar biotechnology companies, with the right to charge exorbitant prices, limit supply through exclusive licensing contracts,

United statesUnited kingdomSouth africaRio de janeiroEstado do rioCosta ricaMinas geraisSouth koreaVilla verdeZain rizviSarah gilbertIshupal kangBill gatesAstrazeneca oxfordHa joon changGonzalo fuentes